Cardio- renal Effect Of Dapagliflozin Alone Versus Dapagliflozin- Saxagliptin Combination In Type 2 Diabetes ( t2dm) Subjects

被引：0
|
作者：
Nandula, Seshagiri Rao R.
Sen, Sabyasachi
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2023年 / 43卷
关键词：
Diabetes (Type II); Endothelial progenitor cell; Extracellular matrix;
D O I：
10.1161/atvb.43.suppl_1.691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A691
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of Dapagliflozin on renal and hepatic glucose kinetics in type 2 diabetes and NGT subjects
    Tripathy, D.
    Solis-Herrera, C.
    Chen, X.
    Hansis-Diarte, A.
    Chilton, R.
    DeFronzo, R.
    Cersosimo, E.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S7 - S7
  • [22] Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk
    Sonesson, C.
    Frederich, R.
    Johansson, P. A.
    Gause-Nilsson, I.
    Langkilde, A. M.
    List, J. F.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1072 - 1072
  • [23] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Donald Elliott Kohan
    Paola Fioretto
    Kristina Johnsson
    Shamik Parikh
    Agata Ptaszynska
    Lisa Ying
    Journal of Nephrology, 2016, 29 : 391 - 400
  • [24] Glucose Production and Utilization following Oral Glucose Load in Type 2 Diabetes Patients Treated with Dapagliflozin Alone and in Saxagliptin Combination
    Qin, Yuejuan
    Gastaldelli, Amalia
    Abdul-Ghani, Muhammad
    Ii, John M. Adams
    Ali, Ali M.
    Eletrebi, Mohamed M.
    Martinez, Robert A.
    Triplitt, Curtis L.
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    DIABETES, 2019, 68
  • [25] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Kohan, Donald Elliott
    Fioretto, Paola
    Johnsson, Kristina
    Parikh, Shamik
    Ptaszynska, Agata
    Ying, Lisa
    JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 391 - 400
  • [26] Dapagliflozin-Saxagliptin Combination - The Quest for Optimal Glycemic Control With Cardio-Renal Protection in Type 2 Diabetes Mellitus: An Expert Consensus in Indian Settings
    Ghosh, Sujoy
    Wangnoo, Subhash K.
    Chittawar, Sachin
    Damodharan, Suresh
    Kadam, Yogesh
    Kalra, Pramila
    Kumar, K. P. Suresh
    Periyandavar, I.
    Sharma, S. K.
    Zargar, Abdul Hamid
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 14 (03) : 128 - 148
  • [27] Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
    Pollock, Carol
    Stefansson, Bergur
    Reyner, Daniel
    Rossing, Peter
    Sjostrom, C. David
    Wheeler, David C.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (06): : 429 - 441
  • [28] Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients
    Reactions Weekly, 2022, 1900 (1) : 6 - 6
  • [29] Dapagliflozin Is Safe and Well Tolerated in Older Patients with T2DM
    Mansfield, Traci
    Fioretto, Paola
    Ptaszynska, Agata
    Yavin, Yshai
    Apanovitch, Anne Marie
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2014, 63 : A71 - A71
  • [30] Haemodynamic effects of dapagliflozin versus hydrochlorothiazide in subjects with type 2 diabetes mellitus
    Heerspink, H. L.
    De Zeeuw, D.
    Wei, L.
    Leslie, B. R.
    List, J. F.
    EUROPEAN HEART JOURNAL, 2012, 33 : 774 - 774
12345